Diabetes mellitus, type 2 Trials in Wichita, United States
Conditions / Diabetes mellitus, type 2 / Wichita, United States
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
42 total trials for this combination
Showing top 10 of 42 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01370005 | 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00838903 | Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01959529 | A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT02730377 | Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes | COMPLETED | PHASE4 |
| NCT01131676 | BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). | COMPLETED | PHASE3 |
| NCT00239538 | SMOOTH - Blood Pressure Control in Diabetic/Obese Patients | COMPLETED | PHASE4 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT01991795 | A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT01720446 | Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01897532 | Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) | COMPLETED | PHASE4 |